Purpose of trial: The purpose of this clinical trial is:
- To monitor effect of treatment on body’s ability to fight cancer
- To study effectiveness of treatment on patients with malignant pleural mesothelioma or malignant pleural effusions
- To monitor any side effects
Eligibility: To be eligible to join this clinical trial you must:
- Be at least 18 years of age
- Have a disease that can be measures or evaluated
- Not have received biological or radiation therapy for at least four weeks
- Not have received bone marrow or stem cell transplantation in the past
- Not have received surgery for at least two weeks
Treatment: The process will entail:
- Placement of catheter between lung and chest wall through which treatment will be administered
- Weekly evaluation for one month; fortnightly evaluation for one month and monthly evaluation for four months. After this patients will receive six monthly evaluations for fifteen years.
Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.